SPORTS MEDICINE
Routine thromboprophylaxis with anticoagulants unnecessary following nonmajor knee arthroscopy
J Thromb Thrombolysis. 2018 May;45(4):562-570Eight randomized controlled trials were selected for inclusion in this meta-analysis which compared rates of thromboembolic complications between groups administered anticoagulants for chemoprophylaxis and control groups following knee arthroscopy. Subgroup analysis was performed for cases of nonmajor knee arthroscopy (ie. procedures without ligament reconstruction). The overall rate of deep vein thrombosis and symptomatic venous thromboembolism was lower in chemoprophylaxis groups compared to control groups. In nonmajor knee arthroscopy procedures, rates of deep vein thrombosis and symptomatic venous thromboembolism did not significantly differ between chemoprophylaxis groups and control groups.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
